Exogenous IL-10 affects the expression of certain cytokines by Th cells and Th17 cells in rats with al-lergic rhinitis
10.3760/cma.j.issn.0254-5101.2014.11.005
- VernacularTitle:外源性IL-10对变应性鼻炎大鼠Th细胞和Th17细胞相关因子表达的影响
- Author:
Weiwei LIU
;
Hongqin WANG
;
Jian LI
;
Baoqiang DAI
;
Xue JIANG
;
Xiaoming SU
;
Peng XU
;
Aiyan JIN
;
Wenna ZUO
- Publication Type:Journal Article
- Keywords:
Allergic rhinitis;
Th1 cells;
Th2 cells;
Th17 cells;
Cytokine
- From:
Chinese Journal of Microbiology and Immunology
2014;(11):839-843
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of IFN-γ, IL-5, IL-17 and TGF-βby Th cells and Th17 cells in rats with allergic rhinitis upon the intervention of IL-10.Methods SD rats were ran-domly divided into three groups including allergic rhinitis ( AR ) group, IL-10 treated group and control group (n=10).Rats in AR group and IL-10 treated group were sensitized by injection of ovalbumin (OVA) and aluminum hydroxide on the 1st, the 7th and the 14th days.The rats treated with equal volume of saline were set up as the control.The corresponding interventions ( OVA, OVA and IL-10, saline) were respec-tively given to rats in each group on the 21th day for 7 consecutive days.The clinical manifestations in rats were observed within 30 minutes after each administration.Serum samples were collected at 48 hours after the last challenge for the detection of IgE and OVA-sIgE.ELISA and Western blot assay were performed to detect IFN-γ, IL-5, IL-17 and TGF-βin nasal mucosa samples.Results Some characteristic symptoms of AR were observed in rats from AR group and IL-10 treated group.Compared with IL-10 treated rats, rats in AR group showed severe clinical symptoms such as constant rubbing and tearing of the eyes (P<0.05).The levels of IgE and OVA-sIgE in serum samples and the levels of IFN-γ, IL-5, IL-17 and TGF-βin nasal tis-sues were significantly increased in rats with RA (P<0.05), but were reduced with IL-10 intervention (P<0.05).Conclusion Exogenous IL-10 could be used to treat AR by reducing the expression of IFN-γ, IL-5, IL-17 and TGF-βin nasal tissues.
